StemCell Institute Inc. (7096.T)
JPY 1329.0
(-0.3%)
JPY 1329.0
(-0.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.57 Billion JPY | 17.97% |
| 2022 | 1.33 Billion JPY | 20.21% |
| 2021 | 1.11 Billion JPY | 20.24% |
| 2020 | 924.2 Million JPY | -18.43% |
| 2019 | 1.13 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 439 Million JPY | 21.56% |
| 2023 Q2 | 410.08 Million JPY | 10.23% |
| 2023 Q4 | 361.14 Million JPY | -16.52% |
| 2023 Q3 | 432.63 Million JPY | 5.5% |
| 2023 FY | 1.57 Billion JPY | 17.97% |
| 2023 Q1 | 372.02 Million JPY | 14.28% |
| 2022 Q3 | 355.35 Million JPY | 3.76% |
| 2022 FY | 1.33 Billion JPY | 20.21% |
| 2022 Q4 | 325.54 Million JPY | -8.39% |
| 2022 Q2 | 342.49 Million JPY | 0.0% |
| 2021 FY | 1.11 Billion JPY | 20.24% |
| 2020 FY | 924.2 Million JPY | -18.43% |
| 2019 FY | 1.13 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 16.234% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -1862.347% |
| GNI Group Ltd. | 22.43 Billion JPY | 92.975% |
| Linical Co., Ltd. | 3.77 Billion JPY | 58.291% |
| Trans Genic Inc. | 2.24 Billion JPY | 29.938% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -1503.918% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 36.517% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | -21.915% |
| AnGes, Inc. | -3.06 Billion JPY | 151.411% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 986.732% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 83.693% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -204.64% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -1320.277% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | -8.637% |
| CanBas Co., Ltd. | -984 Million JPY | 260.151% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -302.321% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 4.847% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -295.359% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -51.617% |
| PeptiDream Inc. | 17.21 Billion JPY | 90.848% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -5049.1% |
| Ribomic Inc. | -10.5 Million JPY | 15105.542% |
| SanBio Company Limited | -14.5 Million JPY | 10965.154% |
| Healios K.K. | 108 Million JPY | -1359.15% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 462235.484% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 2768.906% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 104325.0% |
| StemRIM | -44.34 Million JPY | 3653.365% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 50.522% |
| FunPep Company Limited | -680.28 Million JPY | 331.65% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -2175.642% |
| Stella Pharma Corporation | 217.29 Million JPY | -625.217% |
| TMS Co., Ltd. | -6.95 Million JPY | 22774.561% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -400.978% |
| Cuorips Inc. | 9.63 Million JPY | -16262.6% |
| K Pharma,Inc. | 910 Million JPY | -73.174% |
| Takara Bio Inc. | 25.45 Billion JPY | 93.81% |
| ReproCELL Incorporated | 1.1 Billion JPY | -42.65% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -31.867% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 5.454% |
| CellSeed Inc. | 107.15 Million JPY | -1370.657% |